Clinical Challenges: ADCs and Triple-Negative Breast Cancer
(MedPage Today) -- Triple-negative breast cancer (TNBC)--i.e., breast cancer that does not express estrogen, progesterone, or HER2 receptors--comprises approximately 10%-20% of all breast cancers and represents "an unmet need in the field...
Read more »